Investors bought shares of CVS Health Corporation (NYSE:CVS) on weakness during trading hours on Friday. $111.51 million flowed into the stock on the tick-up and $45.60 million flowed out of the stock on the tick-down, for a money net flow of $65.91 million into the stock. Of all stocks tracked, CVS Health Corporation had the 22nd highest net in-flow for the day. CVS Health Corporation traded down ($0.37) for the day and closed at $97.09

CVS has been the topic of several recent research reports. Morgan Stanley lowered shares of CVS Health Corporation from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $111.00 to $104.00 in a research report on Monday, June 20th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $115.00 price objective on shares of CVS Health Corporation in a research report on Sunday, June 5th. Jefferies Group reaffirmed a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 4th. Deutsche Bank AG raised their price objective on shares of CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a research report on Wednesday, June 22nd. Finally, Vetr raised shares of CVS Health Corporation from a “hold” rating to a “buy” rating and set a $113.29 price objective on the stock in a research report on Monday, April 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $113.72.

The firm has a market capitalization of $104.28 billion and a price-to-earnings ratio of 21.10. The stock’s 50-day moving average price is $95.68 and its 200-day moving average price is $98.34.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, May 3rd. The pharmacy operator reported $1.18 earnings per share for the quarter, beating analysts’ consensus estimates of $1.16 by $0.02. The business earned $43.20 billion during the quarter, compared to the consensus estimate of $43.01 billion. During the same quarter last year, the company posted $1.14 EPS. The firm’s revenue was up 18.9% on a year-over-year basis. Equities analysts predict that CVS Health Corporation will post $5.82 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 1st. Investors of record on Thursday, July 21st will be paid a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date of this dividend is Tuesday, July 19th.

In related news, EVP Troyen A. Brennan sold 7,517 shares of the stock in a transaction on Thursday, May 5th. The stock was sold at an average price of $105.00, for a total value of $789,285.00. Following the sale, the executive vice president now owns 69,601 shares in the company, valued at approximately $7,308,105. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Larry J. Merlo sold 38,247 shares of the stock in a transaction on Thursday, May 5th. The shares were sold at an average price of $105.00, for a total value of $4,015,935.00. Following the completion of the sale, the chief executive officer now owns 280,381 shares in the company, valued at approximately $29,440,005. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors have recently bought and sold shares of the company. Brown Advisory Securities LLC boosted its position in CVS Health Corporation by 14.8% in the fourth quarter. Brown Advisory Securities LLC now owns 10,306 shares of the pharmacy operator’s stock valued at $1,006,000 after buying an additional 1,331 shares during the last quarter. NEXT Financial Group Inc boosted its position in CVS Health Corporation by 1.5% in the fourth quarter. NEXT Financial Group Inc now owns 10,611 shares of the pharmacy operator’s stock valued at $1,037,000 after buying an additional 155 shares during the last quarter. Sawtooth Asset Management Inc. boosted its position in CVS Health Corporation by 96.0% in the fourth quarter. Sawtooth Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock valued at $1,039,000 after buying an additional 5,203 shares during the last quarter. Checchi Capital Advisers LLC boosted its position in CVS Health Corporation by 9.0% in the fourth quarter. Checchi Capital Advisers LLC now owns 10,701 shares of the pharmacy operator’s stock valued at $1,046,000 after buying an additional 882 shares during the last quarter. Finally, WMS Partners LLC boosted its position in CVS Health Corporation by 1.4% in the fourth quarter. WMS Partners LLC now owns 11,098 shares of the pharmacy operator’s stock valued at $1,085,000 after buying an additional 158 shares during the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.